Human Milk Oligosaccharides Market Intelligence Report - Global Forecast to 2027

Human Milk Oligosaccharides Market Intelligence Report - Global Forecast to 2027

The Global Human Milk Oligosaccharides Market is projected to reach USD 420.02 million by 2027 from USD 253.93 million in 2021, at a CAGR 8.74% during the forecast period.

Market Statistics:

The report provides market sizing and forecast across 7 major currencies - USD, EUR, JPY, GBP, AUD, CAD, and CHF. It helps organization leaders make better decisions when currency exchange data is readily available. In this report, the years 2019 and 2020 are considered historical years, 2021 as the base year, 2022 as the estimated year, and years from 2023 to 2027 are considered the forecast period.

• The Americas Human Milk Oligosaccharides Market size was estimated at USD 123.61 million in 2021 and expected to reach USD 133.76 million in 2022, at a CAGR 8.74% to reach USD 204.46 million by 2027.
• The Asia-Pacific Human Milk Oligosaccharides Market size was estimated at USD 48.65 million in 2021 and expected to reach USD 52.71 million in 2022, at a CAGR 8.79% to reach USD 80.68 million by 2027.
• The Europe, Middle East & Africa Human Milk Oligosaccharides Market size was estimated at USD 81.66 million in 2021 and expected to reach USD 88.30 million in 2022, at a CAGR 8.72% to reach USD 134.87 million by 2027.

Market Segmentation & Coverage:

The report on human milk oligosaccharides identifies key attributes about the customer to define the potential market and identify different needs across the industry. Understanding the potential customer group's economies and geographies can help gain business acumen for better strategic decision-making. Our market coverage across different industry verticals reveals the hidden truth about the players' strategies in different verticals and helps the organization decide target audience. This report gives you the composite view of sub-markets coupled with comprehensive industry coverage and provides you with the right way of accounting factors such as norms & regulations, culture, to make right coverage strategy for your market plan.

This research report categorizes the human milk oligosaccharides to forecast the revenues and analyze the trends in each of the following sub-markets:

Product:

• 2’-Fucosyllactose(2’FL)
• 3’-Fucosyllactose (3’FL)
• 3’-Sialyllactose (3’SL)
• 6’-Sialyllactose (6’SL)
• Lacto-n-neotetraose (LNnT)
• Lacto-n-tetraose (LNT)

Type:

• Acidic
• Neutral

Application:

• Functional Food & Supplements
• Infant Formulas
• Laboratory Research

Region:

• Americas
  • Argentina
  • Brazil
  • Canada
  • Mexico
  • United States
    • California
    • Connecticut
    • Florida
    • Illinois
    • Maryland
    • Minnesota
    • New Jersey
    • New York
    • Ohio
    • Pennsylvania
    • Texas
    • Washington
• Asia-Pacific
  • Australia
  • China
  • India
  • Indonesia
  • Japan
  • Malaysia
  • Philippines
  • Singapore
  • South Korea
  • Taiwan
  • Thailand
• Europe, Middle East & Africa
  • France
  • Germany
  • Italy
  • Netherlands
  • Qatar
  • Russia
  • Saudi Arabia
  • South Africa
  • Spain
  • United Arab Emirates
  • United Kingdom

Company Usability Profiles:

• Abbott Laboratories Inc.
• Advanced Protein Technologies Corp.
• Agilent Technologies, Inc.
• BASF SE
• Carbosynth Ltd
• Chr. Hansen Holding A/S
• Dextra Laboratories Limited
• DuPont de Nemours, Inc.
• Elicityl SA
• Glycosyn LLC
• Gnubiotics
• Inbiose NV
• Laïta Nutrition
• Lonza Group AG
• Roquette Frères
• Royal DSM
• Royal FrieslandCampina N.V.
• TurtleTree Labs
• ZuChem, Inc.